Piramal Pharma Ltd. has reappointed veteran finance professional Jairaj Purandare as a Non-Executive Independent Director for a second term of five years, effective February 9, 2026. The company’s Board approved the decision of Directors at its meeting held on Wednesday, subject to shareholders’ approval.
This reappointment follows a recommendation by the Nomination and Remuneration Committee and comes under Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations.
Purandare, who has served on the Piramal Pharma board since 2021, brings extensive experience in the fields of auditing, taxation, and advisory. He is the Founder Chairman of JMP Advisors Pvt Ltd. His previous associations have been with firms in various roles such as Regional Managing Partner, Chairman – Tax and Country Leader, Markets & Industries of PricewaterhouseCoopers (PwC) India, Chairman of Ernst & Young India (EY), and Country Head of the Tax & Business Advisory practice of Andersen India.
His continued association is expected to further strengthen the company’s oversight and strategic direction amid a dynamic regulatory environment. The reappointment underscores the company’s commitment to maintaining high standards of corporate governance.
